T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture
23 sept. 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
20 sept. 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients
16 sept. 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Provides Updates on its New Product Development Pipeline Progress
09 sept. 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
27 août 2024 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems to Attend Upcoming Investor Conferences
01 août 2024 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Second Quarter 2024 Financial Results
29 juil. 2024 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor
29 juil. 2024 16h02 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the...
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
22 juil. 2024 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
25 juin 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the...